Frontlight ResearchEarly access
CompletedNo phase
Flu Infection at UPHS
Key facts
- Who runs it
- University of Pennsylvania
- Where
- Philadelphia, United StatesSee the site
- Trial code
- Status
- Completed
- People taking part
- 19 people enrolled
- Started
- 27 Jan 2025
- Ended
- 29 Sept 2026
- Type of study
- Observational
- Treatments tested
- influenza virus infection
- Record updated
- 7 October 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 15 criteriaShow less
Who can take part
- Provision of signed and dated informed consent form
- Stated willingness to comply with all study procedures and availability for the duration of the study
- Aged 18 years and older
- Influenza positive test result performed within the University of Pennsylvania Health System
Who cannot take part
- Immunosuppression as a result of an underlying illness or treatment with immunosuppressive or cytotoxic drugs, or use of anticancer chemotherapy or radiation therapy within the preceding 36 months
- Treatment with immunoglobulin or another blood product within the 3 months prior to enrollment in this study
- Any neoplastic disease (excluding non-melanoma skin cancer or prostate cancer that is stable in the absence of therapy) or a history of any hematological malignancy ("active" is defined as having received treatment within the past 5 years)
- Known latex allergy
- Known acute or chronic medical condition that, in the opinion of the investigator or appropriate sub-investigator, would interfere with the evaluation of immune responses
- A known human immunodeficiency virus, hepatitis B, or hepatitis C infection
- Any condition that would, in the opinion of the site investigator, place the subject at an unacceptable risk of injury or render the subject unable to meet the requirements of the protocol
- Pregnancy due to the volume of blood collected in this study
- Intends to donate blood during the study period
- Prolonged inpatient hospitalization that disrupts or interferes with study procedures
- Weigh less than 110lbs
Where in United States
- Penn Presbyterian Medical CenterPhiladelphia, United States
About the trial
What the trial wants to find out
Cellular and humoral immune responses in individuals with active influenza infection will be assessed. Each year, up to 50 participants will be enrolled. The investigators hypothesize that influenza infection will elicit mostly memory immune responses rather than de novo immune responses to infection.
Treatments tested
- influenza virus infection
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Evaluating Immune Imprinting in the Context of Influenza Virus Infections
- Record updated
- 7 October 2026